World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 7 January 2013
Main ID:  NCT00001454
Date of registration: 03/11/1999
Primary sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Public title: Hormonal Effects on the Uterus and Endometrium
Scientific title: Endometrial Mediators of Gonadal Steroid Action
Date of first enrolment: April 1995
Target sample size: 203
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT00001454
Study type:  Observational
Study design:  N/A  
Countries of recruitment
United States
Contacts
Name:   For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL)
Address: 
Telephone: 800-411-1222
Email: prpl@mail.cc.nih.gov
Affiliation: 
Name:   Lynnette K Nieman, M.D.
Address: 
Telephone: (301) 496-8935
Email: niemanl@cc1.nichd.nih.gov
Affiliation: 
Name:   Lynnette K Nieman, M.D.
Address: 
Telephone:
Email:
Affiliation:  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Key inclusion & exclusion criteria

- INCLUSION CRITERIA:

Healthy volunteers will be in excellent health.

Only women with regular menstrual cycles (every 26-35 days) using mechanical (condoms,
diaphragm) or sterilization methods of contraception will be included.

Only women with a negative pregnancy test, normal physical examination and laboratory
results, and a luteal phase progesterone value of greater than 4 ng/mL will be entered
into this study.

Women with endometriosis will be recruited from those with histologically-proven
endometriosis. Except for this diagnosis they will meet criteria for healthy volunteers
as stated above.

Women may participate in the study on more than one occasion, but biopsies may not be
performed in a "baseline" cycle.



Age minimum: 18 Years
Age maximum: 43 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Pregnancy
Intervention(s)
Primary Outcome(s)
Secondary Outcome(s)
Secondary ID(s)
95-CH-0110
950110
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history